1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Bondarenko, V. Mowrey, D. Tillman, T. Cui, T. Liu, L.T. Xu, Y. Tang, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE Biochim.Biophys.Acta BBACAQ 0113 0006-3002 1818 1261 1268 10.1016/j.bbamem.2012.02.008 22361591 NMR structures of the transmembrane domains of the a4b2 nAChR. 2012 10.2210/pdb2lm2/pdb pdb_00002lm2 15085.798 Neuronal acetylcholine receptor subunit beta-2 Helical transmembrane region, residues 234-330 and residues 458-484 R231E, R232E, K233E, L292S, V294S, L296S, K299E, T327E 1 man polymer no no SNAEEEPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSSDSPSVGEYLMFTMVL VTFSIVTSVCVLNVHHRSPETHTGGGGGIDRLFLWIFVFVCVFGTIGMFLQPLFQEE SNAEEEPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSSDSPSVGEYLMFTMVL VTFSIVTSVCVLNVHHRSPETHTGGGGGIDRLFLWIFVFVCVFGTIGMFLQPLFQEE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample CHRNB2 9606 Homo sapiens 562 Escherichia coli pTBSG1 database_2 pdbx_database_status pdbx_nmr_spectrometer struct_ref_seq_dif repository Initial release Data collection Database references Other 1 0 2012-03-28 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details BMRB Y RCSB 2011-11-18 REL REL REL REL 766 328 35 114 289 292 0 0 92 92 structures with the lowest energy 100 20 3D 1H-15N NOESY 3D 1H-15N NOESY 3D 1H-13C NOESY 3D HNCA 3D HN(CO)CA 3D HNCO 2D 1H-15N HSQC 2D 1H-13C HSQC 0.25 mM [U-100% 13C; U-100% 15N] 5 mM 1.5 % 0.1 mM 5 % [U-100% 2H] 10 mM 20 mM 4.65 ambient 318 K simulated annealing 1 closest to the average 0.25 mM [U-100% 13C; U-100% 15N] protein, 5 mM sodium acetate, 1.5 % LDAO, 0.1 mM DSS, 5 % [U-100% 2H] D2O, 10 mM sodium chloride, 20 mM beta-mercaptoethanol, 95% H2O/5% D2O 95% H2O/5% D2O Guntert, Mumenthaler and Wuthrich structure solution CYANA 3.0 Guntert, Mumenthaler and Wuthrich refinement CYANA 3.0 600 Bruker AVANCE Bruker Avance 700 Bruker AVANCE Bruker Avance 800 Bruker AVANCE Bruker Avance 900 Bruker AVANCE Bruker Avance n 1 1 A ASN 2 n 2 ASN 2 A ALA 3 n 3 ALA 3 A GLU 4 n 4 GLU 4 A GLU 5 n 5 GLU 5 A GLU 6 n 6 GLU 6 A PRO 7 n 7 PRO 7 A LEU 8 n 8 LEU 8 A PHE 9 n 9 PHE 9 A TYR 10 n 10 TYR 10 A THR 11 n 11 THR 11 A ILE 12 n 12 ILE 12 A ASN 13 n 13 ASN 13 A LEU 14 n 14 LEU 14 A ILE 15 n 15 ILE 15 A ILE 16 n 16 ILE 16 A PRO 17 n 17 PRO 17 A CYS 18 n 18 CYS 18 A VAL 19 n 19 VAL 19 A LEU 20 n 20 LEU 20 A ILE 21 n 21 ILE 21 A THR 22 n 22 THR 22 A SER 23 n 23 SER 23 A LEU 24 n 24 LEU 24 A ALA 25 n 25 ALA 25 A ILE 26 n 26 ILE 26 A LEU 27 n 27 LEU 27 A VAL 28 n 28 VAL 28 A PHE 29 n 29 PHE 29 A TYR 30 n 30 TYR 30 A LEU 31 n 31 LEU 31 A PRO 32 n 32 PRO 32 A SER 33 n 33 SER 33 A ASP 34 n 34 ASP 34 A CYS 35 n 35 CYS 35 A GLY 36 n 36 GLY 36 A GLU 37 n 37 GLU 37 A LYS 38 n 38 LYS 38 A MET 39 n 39 MET 39 A THR 40 n 40 THR 40 A LEU 41 n 41 LEU 41 A CYS 42 n 42 CYS 42 A ILE 43 n 43 ILE 43 A SER 44 n 44 SER 44 A VAL 45 n 45 VAL 45 A LEU 46 n 46 LEU 46 A LEU 47 n 47 LEU 47 A ALA 48 n 48 ALA 48 A LEU 49 n 49 LEU 49 A THR 50 n 50 THR 50 A VAL 51 n 51 VAL 51 A PHE 52 n 52 PHE 52 A LEU 53 n 53 LEU 53 A LEU 54 n 54 LEU 54 A LEU 55 n 55 LEU 55 A ILE 56 n 56 ILE 56 A SER 57 n 57 SER 57 A LYS 58 n 58 LYS 58 A ILE 59 n 59 ILE 59 A VAL 60 n 60 VAL 60 A PRO 61 n 61 PRO 61 A PRO 62 n 62 PRO 62 A THR 63 n 63 THR 63 A SER 64 n 64 SER 64 A SER 65 n 65 SER 65 A ASP 66 n 66 ASP 66 A SER 67 n 67 SER 67 A PRO 68 n 68 PRO 68 A SER 69 n 69 SER 69 A VAL 70 n 70 VAL 70 A GLY 71 n 71 GLY 71 A GLU 72 n 72 GLU 72 A TYR 73 n 73 TYR 73 A LEU 74 n 74 LEU 74 A MET 75 n 75 MET 75 A PHE 76 n 76 PHE 76 A THR 77 n 77 THR 77 A MET 78 n 78 MET 78 A VAL 79 n 79 VAL 79 A LEU 80 n 80 LEU 80 A VAL 81 n 81 VAL 81 A THR 82 n 82 THR 82 A PHE 83 n 83 PHE 83 A SER 84 n 84 SER 84 A ILE 85 n 85 ILE 85 A VAL 86 n 86 VAL 86 A THR 87 n 87 THR 87 A SER 88 n 88 SER 88 A VAL 89 n 89 VAL 89 A CYS 90 n 90 CYS 90 A VAL 91 n 91 VAL 91 A LEU 92 n 92 LEU 92 A ASN 93 n 93 ASN 93 A VAL 94 n 94 VAL 94 A HIS 95 n 95 HIS 95 A HIS 96 n 96 HIS 96 A ARG 97 n 97 ARG 97 A SER 98 n 98 SER 98 A PRO 99 n 99 PRO 99 A GLU 100 n 100 GLU 100 A THR 101 n 101 THR 101 A HIS 102 n 102 HIS 102 A THR 103 n 103 THR 103 A GLY 104 n 104 GLY 104 A GLY 105 n 105 GLY 105 A GLY 106 n 106 GLY 106 A GLY 107 n 107 GLY 107 A GLY 108 n 108 GLY 108 A ILE 109 n 109 ILE 109 A ASP 110 n 110 ASP 110 A ARG 111 n 111 ARG 111 A LEU 112 n 112 LEU 112 A PHE 113 n 113 PHE 113 A LEU 114 n 114 LEU 114 A TRP 115 n 115 TRP 115 A ILE 116 n 116 ILE 116 A PHE 117 n 117 PHE 117 A VAL 118 n 118 VAL 118 A PHE 119 n 119 PHE 119 A VAL 120 n 120 VAL 120 A CYS 121 n 121 CYS 121 A VAL 122 n 122 VAL 122 A PHE 123 n 123 PHE 123 A GLY 124 n 124 GLY 124 A THR 125 n 125 THR 125 A ILE 126 n 126 ILE 126 A GLY 127 n 127 GLY 127 A MET 128 n 128 MET 128 A PHE 129 n 129 PHE 129 A LEU 130 n 130 LEU 130 A GLN 131 n 131 GLN 131 A PRO 132 n 132 PRO 132 A LEU 133 n 133 LEU 133 A PHE 134 n 134 PHE 134 A GLN 135 n 135 GLN 135 A GLU 136 n 136 GLU 136 A GLU 137 n 137 GLU 137 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A SER 1 A SER 1 1 Y 2 A SER 1 A SER 1 1 Y 3 A SER 1 A SER 1 1 Y 4 A SER 1 A SER 1 1 Y 5 A SER 1 A SER 1 1 Y 6 A SER 1 A SER 1 1 Y 7 A SER 1 A SER 1 1 Y 8 A SER 1 A SER 1 1 Y 9 A SER 1 A SER 1 1 Y 10 A SER 1 A SER 1 1 Y 11 A SER 1 A SER 1 1 Y 12 A SER 1 A SER 1 1 Y 13 A SER 1 A SER 1 1 Y 14 A SER 1 A SER 1 1 Y 15 A SER 1 A SER 1 1 Y 16 A SER 1 A SER 1 1 Y 17 A SER 1 A SER 1 1 Y 18 A SER 1 A SER 1 1 Y 19 A SER 1 A SER 1 1 Y 20 A SER 1 A SER 1 1 Y 1 A LEU 31 -116.07 71.69 1 A PRO 32 -69.72 81.58 1 A ASP 34 60.80 -177.19 1 A VAL 60 64.93 75.07 1 A SER 64 -156.97 27.28 1 A ARG 97 59.56 176.32 1 A HIS 102 -61.35 -172.29 1 A PHE 134 -174.77 -178.22 1 A GLU 136 -108.46 63.61 2 A PRO 32 -69.73 97.15 2 A ILE 59 65.94 108.46 2 A VAL 60 -157.45 69.26 2 A SER 64 -59.67 99.08 2 A HIS 95 -155.40 -54.70 2 A HIS 96 60.03 97.35 2 A PHE 134 -174.65 -179.20 2 A GLU 136 -104.01 56.12 3 A PRO 32 -69.73 85.38 3 A SER 67 61.91 71.81 3 A HIS 96 58.07 77.39 3 A ARG 97 62.03 -176.80 3 A PHE 134 -177.93 -177.59 3 A GLU 136 -92.41 51.51 4 A ALA 3 -164.31 43.96 4 A LEU 31 -119.90 68.68 4 A PRO 32 -69.83 80.55 4 A SER 65 62.33 177.99 4 A ASN 93 -178.70 134.40 4 A THR 103 -145.71 55.14 4 A GLU 136 58.45 82.18 5 A PRO 32 -69.75 83.69 5 A SER 65 -57.61 171.59 5 A PRO 68 -69.81 -175.44 5 A SER 69 -132.28 -60.91 5 A VAL 94 -171.56 141.07 5 A THR 101 -69.56 99.41 5 A GLU 136 56.53 73.49 6 A GLU 6 178.55 -59.24 6 A ILE 59 65.93 110.86 6 A THR 63 -170.39 -38.31 6 A ASP 66 -171.58 -41.17 6 A ARG 97 62.02 175.37 7 A SER 64 -172.02 147.51 7 A SER 67 -152.18 69.68 7 A THR 101 -174.92 86.85 7 A PHE 134 -171.30 -178.03 7 A GLU 136 59.84 78.06 8 A GLU 6 178.52 -59.19 8 A LEU 31 -116.00 71.02 8 A SER 65 -178.24 114.90 8 A ASP 66 58.81 91.97 8 A SER 67 60.14 72.26 8 A ASN 93 -172.26 125.74 8 A HIS 95 -165.93 -49.50 8 A ARG 97 -145.78 24.39 8 A PHE 134 -173.07 -179.21 8 A GLU 136 56.78 77.55 9 A GLU 5 60.91 94.87 9 A GLU 6 178.55 -59.17 9 A SER 64 -166.76 79.66 9 A SER 65 -122.00 -67.97 9 A PRO 68 -69.80 -179.37 9 A SER 69 -143.68 -68.69 9 A HIS 95 -172.47 132.59 9 A GLU 136 55.26 90.89 10 A LEU 31 -118.71 70.44 10 A ILE 59 66.13 149.31 10 A SER 64 -178.98 -171.13 10 A ASP 66 -179.13 -177.66 10 A SER 69 63.01 89.91 10 A HIS 95 -163.63 118.30 10 A HIS 102 -127.31 -73.74 10 A PHE 134 -173.05 -179.06 10 A GLU 136 56.21 85.12 11 A ILE 59 65.91 111.77 11 A VAL 60 -119.18 73.04 11 A THR 63 -161.78 31.02 11 A SER 64 62.93 103.71 11 A SER 65 -160.68 -72.62 11 A HIS 95 -166.51 61.83 11 A HIS 96 -152.28 -54.36 11 A PHE 134 -174.53 -77.43 11 A GLU 136 56.03 92.69 12 A GLU 5 -99.43 42.20 12 A GLU 100 -176.48 144.75 12 A THR 101 -55.01 172.28 12 A PHE 134 -174.29 -77.40 12 A GLU 136 55.41 84.09 13 A ASP 34 -98.48 45.32 13 A ILE 59 -119.81 62.18 13 A SER 65 -164.16 -73.42 13 A ASP 66 -129.07 -53.94 13 A SER 67 -117.44 70.33 13 A ASN 93 -174.92 149.13 13 A SER 98 63.08 160.54 13 A HIS 102 -125.37 -64.99 13 A GLU 136 53.42 72.67 14 A ALA 3 58.59 94.88 14 A ASP 34 -116.54 -74.29 14 A SER 67 -171.84 70.13 14 A SER 69 -145.59 24.83 14 A HIS 96 62.79 163.83 14 A ARG 97 -170.05 124.15 14 A GLU 136 57.97 74.96 15 A ALA 3 -168.66 100.90 15 A ASP 34 63.13 167.68 15 A ILE 59 65.92 111.90 15 A THR 63 -176.36 -37.79 15 A ASP 66 -177.40 -42.34 15 A HIS 96 -160.15 90.82 15 A PHE 134 180.00 -77.67 16 A ALA 3 -59.22 108.42 16 A GLU 5 54.98 90.91 16 A GLU 6 178.56 -59.20 16 A SER 65 -124.02 -62.49 16 A SER 67 52.46 73.06 16 A PRO 68 -69.78 -177.92 16 A SER 69 -139.31 -74.35 16 A HIS 96 58.42 85.35 16 A GLU 100 61.16 98.46 16 A PHE 134 -172.44 -179.00 17 A ALA 3 -156.44 70.44 17 A ASP 34 61.08 174.08 17 A VAL 60 -113.45 74.20 17 A SER 67 63.02 70.88 17 A HIS 96 62.92 171.13 17 A GLU 136 56.10 72.72 18 A GLU 5 62.86 104.11 18 A GLU 6 178.57 -59.26 18 A PRO 32 -69.75 81.10 18 A SER 65 -170.10 -51.59 18 A PHE 134 -171.78 -177.33 19 A PRO 32 -69.74 96.49 19 A VAL 60 -113.43 74.27 19 A ASP 66 59.97 94.79 19 A SER 67 56.04 70.88 19 A HIS 95 -176.80 -46.51 19 A GLU 136 55.22 89.42 20 A ALA 3 -177.35 -49.54 20 A PRO 32 -69.73 92.96 20 A ASP 34 62.45 171.98 20 A ILE 59 -119.80 63.09 20 A THR 63 -172.25 115.13 20 A SER 67 53.35 71.54 20 A HIS 96 61.72 169.62 20 A PHE 134 -173.88 -77.49 20 A GLU 136 52.49 83.06 closest to the average, model 17 NMR structures of the transmembrane domains of the AChR b2 subunit 1 N N A PRO 7 A PRO 7 HELX_P A LEU 31 A LEU 31 1 1 25 A CYS 35 A CYS 35 HELX_P A ILE 59 A ILE 59 1 2 25 A PRO 61 A PRO 61 HELX_P A SER 65 A SER 65 5 3 5 A SER 69 A SER 69 HELX_P A ASN 93 A ASN 93 1 4 25 A GLY 108 A GLY 108 HELX_P A LEU 130 A LEU 130 1 5 23 TRANSPORT PROTEIN Acetylcholine receptor, Transmembrane domain, TRANSPORT PROTEIN ACHB2_HUMAN UNP 1 231 P17787 RRKPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSLDVPLVGKYLMFTMVLVTF SIVTSVCVLNVHHRSPTTHT ACHB2_HUMAN UNP 1 458 P17787 IDRLFLWIFVFVCVFGTIGMFLQPLFQNY 231 330 2LM2 4 103 P17787 A 1 4 103 458 486 2LM2 109 137 P17787 A 2 109 137 1 expression tag SER 1 2LM2 A P17787 UNP 1 1 expression tag ASN 2 2LM2 A P17787 UNP 2 1 expression tag ALA 3 2LM2 A P17787 UNP 3 1 ARG engineered mutation GLU 4 2LM2 A P17787 UNP 231 4 1 ARG engineered mutation GLU 5 2LM2 A P17787 UNP 232 5 1 LYS engineered mutation GLU 6 2LM2 A P17787 UNP 233 6 1 LEU engineered mutation SER 65 2LM2 A P17787 UNP 292 65 1 VAL engineered mutation SER 67 2LM2 A P17787 UNP 294 67 1 LEU engineered mutation SER 69 2LM2 A P17787 UNP 296 69 1 LYS engineered mutation GLU 72 2LM2 A P17787 UNP 299 72 1 THR engineered mutation GLU 100 2LM2 A P17787 UNP 327 100 1 linker GLY 104 2LM2 A P17787 UNP 104 1 linker GLY 105 2LM2 A P17787 UNP 105 1 linker GLY 106 2LM2 A P17787 UNP 106 1 linker GLY 107 2LM2 A P17787 UNP 107 1 linker GLY 108 2LM2 A P17787 UNP 108 2 ASN engineered mutation GLU 136 2LM2 A P17787 UNP 485 136 2 TYR engineered mutation GLU 137 2LM2 A P17787 UNP 486 137